Randy Rongione joined Klein Hersh in 2002 and has helped build the discovery and development practice, with a focus on DMPK, Toxicology, and Neuropharmacology (discovery/preclinical/translational research). Throughout his tenure with Klein Hersh, Randy has enjoyed partnering closely with clients including start up organizations, small to mid-size biotechs, as well as large Pharmaceutical companies.
Randy’s practice brings a unique level of market insight drawing from his experiences of over 15 years of building client companies. Clients that partner with Randy speak to his depth of relationships that he has created, along with the ability to deliver some of the most difficult skill sets in the market.
Prior to KHI, Randy earned a degree from Temple University, with a double major in Political Science and Criminal Justice.